drugset / Trial / NCT06475846
A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS5580 for preventing of postoperative nausea and vomiting in adults. To explore the reasonable dosage of HRS5580 for postoperative nausea and vomiting.
Timeline
- Start
- 2024-06-25
- Primary completion
- 2024-10-29
- Completion
- 2024-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS5580 | Unknown | — | — |
| Comparator | Ondansetron | Other / unclassified | — | — |
Indications
No indication recorded.